Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 29,050
+50 (0.17%)
Jan 30, 2026, 3:30 PM KST
11.95% (1Y)
| Market Cap | 170.52B +12.4% |
| Revenue (ttm) | 209.00B +3.5% |
| Net Income | 31.56B +2.9% |
| EPS | 5,366.74 +2.9% |
| Shares Out | 5.88M |
| PE Ratio | 5.40 |
| Forward PE | 5.60 |
| Dividend | 900.00 (3.10%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 20,619 |
| Average Volume | 17,416 |
| Open | 29,000 |
| Previous Close | 29,000 |
| Day's Range | 28,900 - 29,450 |
| 52-Week Range | 24,750 - 33,950 |
| Beta | 0.17 |
| RSI | 54.75 |
| Earnings Date | Mar 18, 2026 |